Activity Dates: 04/22/2009 - 04/22/2012
This course is closed. Please look for other available products in CPNP University.
If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.
At the intersection of pharmacology and genetics is pharmacogenetics or pharmacogenomics. This rapidly evolving field is one of the cornerstones of Personalized Medicine, however many health care providers do not feel comfortable with the science behind this field nor with the ambiguity in the data that is currently available to support mainstream integration of this field into practice. Thus, the goal of this presentation is to briefly review some of the genetic principals that underlie the field of pharmacogenomics so that health care providers may feel more comfortable in reviewing this literature and be able to understand how to incorporate this science into their practice.
During this session we will review some of the literature regarding the pharmacogenetics of psychiatry and discuss why the literature may be reporting conflicting information. We will also discuss an example of how this science may be clinically used and outline some of the barriers we currently face in incorporation of these data into everyday clinical practice. At the very beginning of the Human Genome Project, pharmacogenetics was outlined as a priority. Although Personalized Medicine using pharmacogenetics has become a reality, or soon will be a reality for many other therapeutic areas, this promise has not yet been realized in the mental health arena. Lastly, we will discuss the role of the Food and Drug Administration on pharmacogenetics as it relates to the drug approval process and package insert information, and discuss some of the direct to consumer laboratories that are currently available for testing and what this might mean to the practice of neuropsychiatric pharmacy.
You will proceed through the following steps to satisfactorily complete this course:
This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.
Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Vicki Ellingrod, PharmD, BCPP, FCCPView biographical information and disclosures
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is #0284-0000-09-013-H01-P (1.0 contact hours).
ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This programming was supported in part by grants from Bristol-Myers Squibb, Forest Laboratories, Inc., Lilly, Schering-Plough, Cyberonics, and Shire.